H1527: Prohibitions Against Discriminatory Practices Relating to 340B Entities and 340B Drugs
Legislative Summary
Prohibits drug manufacturers from engaging in certain acts against acquisitions of 340B drugs by & delivery of such drugs to specified pharmacies; prohibits drug manufacturers from interfering with pharmacies' rights to contract with 340B entities; prohibits certain acts by health insurers, HMOs, pharmacy benefit managers, or other third-party payors, or their agents, relating to reimbursement to 340B entity for 340B drugs; provides that each commission of certain acts constitutes violation of Florida Deceptive & Unfair Trade Practices Act & subjects violator to certain penalties.
Demographic Impact
Overall analysis of equity impact
Unlock Full Demographic Insights
Go beyond the overall score.
Gain a deeper understanding of this bill's potential impact across diverse communities, including detailed breakdowns by category and subgroup. Access to this granular analysis helps ensure equitable outcomes.
Enable full analysis features for your organization.
Contact Sales to Learn MoreOr email us directly at sales@legiequity.us.
Bill History
Status Information
Sponsors
Primary Sponsor
